Dr Amanda Vrselja is Program Head of CUREator, Australia’s leading life sciences incubator. Delivered by Brandon BioCatalyst, CUREator is designed to accelerate research translation and commercialisation by bridging the gap between research and investment readiness for the next generation of medical innovations and biotech start-ups. She joined the program as a part of the founding team in 2021. Previously, Amanda was a Clinical Scientist at QUE Oncology, a venture-backed clinical stage company developing treatments for women experiencing hot flashes associated with hormonal cancer therapy. She was involved in the corporate development and strategy, and managed clinical and research and development program activities, including the delivery of a global phase 2 clinical program. Amanda holds a PhD in Developmental Biology from Monash University.